Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

Technology Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > Stock moves
View:
Post by bluemoons20 on Nov 01, 2022 9:25am

Stock moves

Yhis is just my opinion  but  just  because no  news  (good or  bad)  was released officially at the meeting  does  not mean that there really is no news in the background.

It seems that the  'market'  hears  upcoming news before shareholders  and makes the stock  make unexpected moves.

GLTA
Comment by Ingiboy on Nov 01, 2022 12:35pm
The Oct. 31st meeting has come and gone.  The vote to allow Andrew Schutte to own 22.3% of Replicel was ratified without fanfare.   Now that is in place it will be interesting to see if they are able to sell the remaining 5,500,000 shares with warrants after Andrew buys his 2,500,000.  This PP closes as announced on nov. 18th. This hopefully will give the company adequate funding ...more  
Comment by Ingiboy on Nov 02, 2022 12:11pm
The share price is desperately trying to go up with little or no support. When will these guys wake up and give us an upate which might help to give us some upward momentum.  
Comment by BellEnd on Nov 02, 2022 12:42pm
This post has been removed in accordance with Community Policy
Replicel Life Sciences Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities